Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL)

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares through a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group Inc. and affiliated entities have sold shares of QuidelOrtho Corp (QDEL) on June 14 and June 17, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On June 14, 2024, 22,287 shares were sold at a weighted average price of $35.8208, 104,663 shares were sold at a weighted average price of $36.2618, and 1,031 shares were sold at a weighted average price of $37.0858.
• On June 17, 2024, 51,468 shares were sold at a weighted average price of $35.8156, and 48,174 shares were sold at a weighted average price of $36.1773.
• Following these transactions, the Carlyle Group and affiliated entities still indirectly beneficially own 12,024,063 shares of QuidelOrtho Corp.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports routine transactions under a pre-existing trading plan. No explicit positive or negative implications are stated.

Industry Context

Share sales by major holders like Carlyle Group are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The impact on the stock price depends on the size of the sale relative to the trading volume and overall market sentiment.

Stakeholder Impact

• Shareholders may react to the news of the sale, potentially impacting the stock price in the short term.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal, as the sale does not directly affect the company's operations.

Key Dates